Woohyun Jung1, Sukki Cho2,3, Sungwon Yum1, Jin-Haeng Chung4,5, Kyung Won Lee6,7, Kwhanmien Kim1,8, Choon Taek Lee9,10, Sanghoon Jheon1,8. 1. Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Republic of Korea. 2. Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Republic of Korea. skcho@snubh.org. 3. Department of Thoracic and Cardiovascular Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea. skcho@snubh.org. 4. Department of Pathology, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea. 5. Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea. 6. Department of Radiology, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea. 7. Department of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea. 8. Department of Thoracic and Cardiovascular Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea. 9. Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea. 10. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Abstract
OBJECTIVES: Subsolid lung adenocarcinoma with cystic airspaces (LACA) is a unique manifestation of lung cancer. This study was conducted to establish a radiologic disease progression model of LACA and to explore its association with the clinical course and clinicopathologic features of LACA. MATERIALS AND METHODS: Sixty patients with LACA who underwent surgery at our center between 2004 and 2017 were retrospectively reviewed. The morphological changes of LACA over time on 98 serial computed tomography scans from 27 of 60 patients were tracked to establish a radiologic disease progression model. Associations between this model and the clinicopathologic characteristics of LACA were investigated. RESULTS: The following stepwise progression model of LACA was developed: in phase I, cystic airspaces (CAs) appear in the middle of non-solid nodules; in phase II, the CAs grow; in phase III, a solid component appears on the border of the CAs; and in phase IV, the solid component gradually surrounds the CAs and becomes thicker, and the CAs shrink. In total, 10 (17%), 33 (55%), and 17 (28%) LACA patients were classified as belonging to phases II, III, and IV at the time of surgery, respectively. More advanced phases were associated with higher pathologic T and N staging, lymphovascular invasion, visceral pleural invasion, spread through air spaces, and solid/micropapillary subtype. In the multivariate analysis, our model demonstrated a good discrimination capability for cancer recurrence risk. CONCLUSIONS: The stepwise disease progression model of LACA based on radiologic findings developed in this study represented its natural clinical course and clinicopathologic features well.
OBJECTIVES: Subsolid lung adenocarcinoma with cystic airspaces (LACA) is a unique manifestation of lung cancer. This study was conducted to establish a radiologic disease progression model of LACA and to explore its association with the clinical course and clinicopathologic features of LACA. MATERIALS AND METHODS: Sixty patients with LACA who underwent surgery at our center between 2004 and 2017 were retrospectively reviewed. The morphological changes of LACA over time on 98 serial computed tomography scans from 27 of 60 patients were tracked to establish a radiologic disease progression model. Associations between this model and the clinicopathologic characteristics of LACA were investigated. RESULTS: The following stepwise progression model of LACA was developed: in phase I, cystic airspaces (CAs) appear in the middle of non-solid nodules; in phase II, the CAs grow; in phase III, a solid component appears on the border of the CAs; and in phase IV, the solid component gradually surrounds the CAs and becomes thicker, and the CAs shrink. In total, 10 (17%), 33 (55%), and 17 (28%) LACApatients were classified as belonging to phases II, III, and IV at the time of surgery, respectively. More advanced phases were associated with higher pathologic T and N staging, lymphovascular invasion, visceral pleural invasion, spread through air spaces, and solid/micropapillary subtype. In the multivariate analysis, our model demonstrated a good discrimination capability for cancer recurrence risk. CONCLUSIONS: The stepwise disease progression model of LACA based on radiologic findings developed in this study represented its natural clinical course and clinicopathologic features well.
Authors: Alexander A Bankier; Heber MacMahon; Jin Mo Goo; Geoffrey D Rubin; Cornelia M Schaefer-Prokop; David P Naidich Journal: Radiology Date: 2017-06-26 Impact factor: 11.105
Authors: William D Travis; Elisabeth Brambilla; Andrew G Nicholson; Yasushi Yatabe; John H M Austin; Mary Beth Beasley; Lucian R Chirieac; Sanja Dacic; Edwina Duhig; Douglas B Flieder; Kim Geisinger; Fred R Hirsch; Yuichi Ishikawa; Keith M Kerr; Masayuki Noguchi; Giuseppe Pelosi; Charles A Powell; Ming Sound Tsao; Ignacio Wistuba Journal: J Thorac Oncol Date: 2015-09 Impact factor: 15.609
Authors: Florian J Fintelmann; Jesaja K Brinkmann; William R Jeck; Fabian M Troschel; Subba R Digumarthy; Mari Mino-Kenudson; Jo-Anne O Shepard Journal: J Thorac Imaging Date: 2017-05 Impact factor: 3.000
Authors: Ali O Farooqi; Matt Cham; Lijuan Zhang; Mary Beth Beasley; John H M Austin; Albert Miller; Javier J Zulueta; Heidi Roberts; Cole Enser; Shang-Jyh Kao; M K Thorsen; James P Smith; Daniel M Libby; Rowena Yip; David F Yankelevitz; Claudia I Henschke Journal: AJR Am J Roentgenol Date: 2012-10 Impact factor: 3.959
Authors: Hideki Ujiie; Kyuichi Kadota; Jamie E Chaft; Daniel Buitrago; Camelia S Sima; Ming-Ching Lee; James Huang; William D Travis; Nabil P Rizk; Charles M Rudin; David R Jones; Prasad S Adusumilli Journal: J Clin Oncol Date: 2015-08-10 Impact factor: 44.544